Research articlePublished 2017
Inappropriate Post-Operative Analgesia is Achieved Using Recommended Doses of Sustained-Release Meloxicam in Mice
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Meloxicam is an analgesic NSAID commonly used in mice. Anecdotal evidence supports the use of alternative delivery methods for analgesics including injectable sustained release (SR) formulations as ways to achieve long-term analgesia with less frequent handling; potentially minimizing pain and distress. However, objective data regarding efficacy of these alternative approaches is lacking in the literature. We conducted a pilot study evaluating the efficacy and blood levels of Meloxicam-SR administration in a surgical model (osmotic pump placement), using the manufacturer’s recommended dosing of 4 mg/kg per 72 h. Mice exhibited signs of pain and plasma drug levels were undetectable 4 h after dosing. Meloxicam-SR failed to deliver adequate pain control at the currently recommended dosing; suggesting further studies are needed to determine effective dosing for mice.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Animal Health and Behavioural Science
- SubjectMental Health and Psychology
- SubjectVeterinary & Animal Science
- BylineArticles whose byline prints “Herrod JA”
- BylineArticles whose byline prints “Doane CJ”
- BylineArticles whose byline prints “Veltri CA”
- BylineArticles whose byline prints “Mexas AM”
